Mosby's 2014 Nursing Drug Reference (36 page)

BOOK: Mosby's 2014 Nursing Drug Reference
9.81Mb size Format: txt, pdf, ePub
amoxicillin/clavulanate (Rx)

(a-mox-i-sill′in)

Amoclan, Apo-Amoxi Clav
, Augmentin, Augmentin XR, Clavulin

Func. class.:
Broad-spectrum antiinfective

Chem. class.:
Aminopenicillin β-lactamase inhibitor

Do not confuse:
Augmentin
/amoxicillin

ACTION:

Bacteriocidal, interferes with cell wall replication of susceptible organisms; the cell wall, rendered osmotically unstable, swells and bursts from osmotic pressure; lysis mediated by bacterial cell wall autolytic enzymes, combination increases spectrum of activity against β-lactamase–resistant organisms

USES:

Lower respiratory tract infections, sinus infections, pneumonia, otitis media, skin infection, UTI; effective for strains of
Escherichia coli, Proteus mirabilis, Haemophilus influenzae, Streptococcus faecalis, Streptococcus pneumoniae
, and some β-lactamase–producing organisms

Unlabeled uses:
Actinomycotic mycetoma, chancroid, dental infections, dentoalveolar infection, melioidosis, pericoronitis, SARS

CONTRAINDICATIONS:

Hypersensitivity to penicillins, severe renal disease, dialysis, jaundice

Precautions:
Pregnancy (B), breastfeeding, neonates, children, hypersensitivity to cephalosporins; renal/GI disease, asthma, colitis, diabetes, eczema, leukemia, mononucleosis, viral infections, phenylketonuria

DOSAGE AND ROUTES
Calculator

• Adult: PO
250-500 mg q8hr or 500-875 mg q12hr, depending on severity of infection

• Child ≤40 kg:
PO
20-90 mg/kg/day in divided doses q8-12hr

Renal disease

• Adult: PO
CCr 10-30 ml/min dose q12hr; CCr <10 ml/min dose q24hr; do not use 875-mg strength or ext rel if CCr <30 ml/min; Augmentin XR is contraindicated with renal disease

Available forms:
Tabs 250, 500, 875 mg/125 mg clavulanate; chew tabs 200/28.5, 400/57 mg; powder for oral susp 250/28.5, 200/28.5, 400/57, 600/42.9 mg/5 ml; ext rel tabs (XR) 1000 mg amoxicillin, 62.5 mg clavulanate; powder for oral susp (ES) 600 mg amoxicillin, 42.9 mg clavulanate

Administer:
PO route

• 
Do not break, crush, chew XR (ext rel) product

 
Only as directed; two 250-mg tabs not equivalent to one 500-mg tab due to strength of clavulanate

• 
Shake susp well before each dose; may be used alone, mixed in drinks; use im
mediately, discard unused portion of susp after 14 days, store in refrigerator

• 
Give around the clock

• 
Give with light meal for increased absorption

SIDE EFFECTS

CNS:
Headache, fever,
seizures,
agitation, insomnia

GI:
Nausea, diarrhea, vomiting
, increased AST/ALT, abdominal pain, glossitis, colitis, black tongue,
pseudomembranous colitis

GU:
Oliguria, proteinuria, hematuria,
vaginitis, moniliasis
,
glomerulonephritis

HEMA:
Anemia,
bone marrow depression, granulocytopenia, leukopenia, eosinophilia,
thrombocytopenic purpura

INTEG:
Rash
, urticaria, dermatitis,
toxic epidermal necrolysis

META:
Hypo/hyperkalemia, alkalosis, hypernatremia

SYST:
Anaphylaxis, respiratory distress, serum sickness, superinfection, Stevens-Johnson syndrome,
candidiasis

PHARMACOKINETICS

PO:
Peak 2 hr, duration 6-8 hr, half-life 1-1⅓ hr, metabolized in liver, excreted in urine, crosses placenta, excreted in breast milk, removed by hemodialysis

INTERACTIONS

Increase:
amoxicillin levels—probenecid

Increase:
anticoagulant effect—warfarin

Increase:
skin rash—allopurinol

Decrease:
action of oral contraceptives

Drug/Food

Decrease:
absorption by a high-fat meal

Drug/Lab Test

Increase:
AST/ALT, alk phos, LDH

False positive:
direct Coombs’s test

NURSING CONSIDERATIONS
Assess:

 
Nephrotoxicity at high doses: I&O ratio; report hematuria, oliguria


 
Hepatic studies: AST, ALT

• 
Blood studies: WBC, RBC, Hgb, Hct, bleeding time

• 
Renal studies: urinalysis, protein, blood, BUN, creatinine; if urine output decreases, long-acting products should not be used

• 
C&S before product therapy; product may be given as soon as culture is taken

 
Pseudomembranous colitis:
bowel pattern before, during treatment; diarrhea, cramping, blood in stools; report to prescriber

 
Anaphylaxis:
rash, itching, dyspnea, facial/laryngeal edema; skin eruptions after administration of penicillin to 1 wk after discontinuing product

Perform/provide:

• 
Adrenaline, suction, tracheostomy set, endotracheal intubation equipment on unit

• 
Adequate intake of fluids (2 L) during diarrhea episodes

• 
Scratch test to assess allergy after securing order from prescriber; usually done when penicillin is only product of choice

• 
Storage in refrigerator for 10 days

Evaluate:

• 
Therapeutic response: absence of infection

Teach patient/family:

• 
To take as prescribed, not to double dose

• 
All aspects of product therapy: to complete entire course of medication to ensure organism death (10-14 days); that culture may be taken after completed course of medication

 
To report sore throat, fever, fatigue
(superinfection or agranulocytosis);
diarrhea, cramping, blood in stools
(pseudomembranous colitis)

• 
That product must be taken in equal intervals around the clock to maintain blood levels

• 
To wear or carry emergency ID if allergic to penicillins

TREATMENT OF HYPERSENSITIVITY:

Withdraw product, maintain airway, administer EPINEPHrine, aminophylline, O
2
, IV corticosteroids for anaphylaxis

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

Other books

Snatchers 2: The Dead Don't Sleep by Whittington, Shaun
Taken by the Duke by Jess Michaels
The Sea Runners by Ivan Doig
The Charming Way by Grayson, Kristine
Behold the Dawn by Weiland, K.M.
A Tale of Two Trucks by Thea Nishimori
The Sculptor by Gregory Funaro
A Walk in the Dark by Gianrico Carofiglio